JOSLIN DIABETES CENTER INC (EIN 042203836) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1950

Legal Domicile

Principal Officer

KEVIN TABB MD

Phone

6173092400

Tax Period

2023-10-01 to 2024-09-30

JOSLIN DIABETES CENTER INC, founded in 1950, is a mid-sized nonprofit in the Diseases & Disorders sector that reported $71.6M in total revenue in fiscal year 2023. Expenses of $81.6M exceeded revenue, resulting in a 14% operating deficit.

Mission

OUR MISSION IS TO PREVENT, TREAT, AND CURE DIABETES. OUR VISION IS A WORLD FREE OF DIABETES AND ITS COMPLICATIONS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $35,828,689

Program Service Revenue $31,596,388

Investment Income $3,443,232

Other Revenue $723,300

TOTAL REVENUE $71,591,609

Expense Breakdown

Grants Paid $9,608,581

Salaries & Benefits $28,961,161

Fundraising Expenses $267,888

Program Expenses $64,225,751

Other Expenses $42,915,342

TOTAL EXPENSES $81,626,334

Year-over-Year Comparison

	2023	2022	Change
Revenue	$71,591,609	$74,197,360	0.0%
Expenses	$81,626,334	$82,769,482	0.0%
Net Income	$-10,034,725	$-8,572,122	+0.2%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

407

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$9,951,367

Total Directors

$8,185,026

Key Employees

$874,122

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ROWAN MICHAEL	TTEE(EXO)(CEO DESIG)EVP HOS&AMB BILH	1.00	Director	$0	$2,401,778	$4,703,895
HEALY PETER	TTEE (EXO) (DIV PRES, METRO BOSTON)	1.00	Director	$0	$84,548	$1,682,157
HERMAN MD PHD ROBERTA	PRESIDENT & TRUSTEE (EX-OFFICIO)	55.00	Officer Director	$919,763	$46,710	$966,473
KING MD GEORGE L	TTEE (EX-OFF); CHIEF SCIENTIFIC OFF	55.00	Director	$431,435	$59,803	$491,238
MEHTA MD SANJEEV	TTEE & SVP, CMO, CMIO, CHF QUAL OFF	55.00	Director	$288,244	$53,019	$341,263
PASQUALINI MARTIN	TRUSTEE & CHAIR	1.00	Officer Director	$0	$0	$0
ABBRECHT TODD	TRUSTEE	1.00	Director	$0	$0	$0
DEVLIN MICHAEL K	TRUSTEE	1.00	Director	$0	$0	$0
ENRIGHT RYAN	TRUSTEE	1.00	Director	$0	$0	$0
MOSES MD ALAN	TRUSTEE	1.00	Director	$0	$0	$0
POLONSKY MD KENNETH	TRUSTEE	1.00	Director	$0	$0	$0
SANNA PHD BASTIANO	TRUSTEE	1.00	Director	$0	$0	$0
WELO KRISTEN	TRUSTEE	1.00	Director	$0	$0	$0
WING LEVERETT	TRUSTEE	1.00	Director	$0	$0	$0
YEE SHUNEE	TRUSTEE	1.00	Director	$0	$0	$0
TABB MD KEVIN	CEO (EX-OFF) (CEO, BILH)	1.00	Officer	$0	$1,097,028	$5,410,415
RIOS CINDY	TREAS (EX-OFF) (EXEC VP & CFO, BILH)	1.00	Officer	$0	$217,736	$1,689,163
KATZ ESQ JAMIE	CLERK (EX-OFF); GENERAL COUNSEL BILH	1.00	Officer	$0	$32,002	$1,302,177
ARMSTRONG ESQ EMILY	ASST CLERK (DIV VP DEP GC BOS, BILH)	1.00	Officer	$0	$41,550	$351,216
BHOGADI SATISH	ASST TREAS (EX-OFF) & ASSISTANT CFO	55.00	Officer	$220,276	$11,647	$231,923
KAHN MD RONALD C	CHIEF ACADEMIC OFFICER	55.00	Key Emp	$412,111	$62,429	$474,540
LIT SUSAN	CHIEF OPERATING OFFICER	55.00	Key Emp	$324,547	$75,035	$399,582
SUN MD MPH JENNIFER K	CHIEF, CENTER EYE RESEARCH & TRIALS	55.00	Highest	$398,845	$52,301	$451,146
LARRABEE MD JOAN	PHYS, ENDOCRINE/DIABETES/METABOLISM	55.00	Highest	$313,047	$60,902	$373,949
SHARUK MD GEORGE S	OPHTHALMOLOGIST	55.00	Highest	$315,829	$58,117	$373,946
HAMDY MD MPH OSAMA	PHYS, ENDOCRINE/DIABETES/METABOLISM	55.00	Highest	$301,429	$61,348	$362,777
HALPRIN MD ELIZABETH	SECTION CHIEF, ADULT DIABETES	55.00	Highest	$303,671	$57,759	$361,430
BUCKLEY ESQ MARIA D	FORMER CLERK, GENERAL COUNSEL	0.00		$231,268	$13,068	$244,336
AIELLO PHD LLOYD-PAUL	FORMER VICE PRESIDENT, OPTHAMOLOGY	0.00		$388,625	$53,432	$442,057

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$71,591,609	$81,626,334	$176,840,438	$-10,034,725
2023	$74,197,360	$82,769,482	$166,005,908	$-8,572,122
2022	$134,166,466	$98,047,633	$158,601,430	$36,118,833
2021	$81,813,666	$90,420,592	$119,817,710	$-8,606,926
2020	$76,953,905	$96,451,661	$107,556,453	$-19,497,756
2019	$80,200,703	$94,714,085	$116,544,681	$-14,513,382
2018	$98,325,080	$91,783,272	$129,902,651	$6,541,808

JOSLIN DIABETES CENTER INC